![(4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone(S)-1-(4-fluorophenyl)-5-(2-oxo-4-phenyloxazolidin-3-yl)pentane-1,5-dione](/sites/pharmaceutiucal-materials.com/files/oldimages/937588941.jpg)
Product name: (4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone/(S)-1-(4-fluorophenyl)-5-(2-oxo-4-phenyloxazolidin-3-yl)pentane-1,5-dione
CAS:189028-93-1
Molecular formula:C20H18FNO4
Molecular weight:355.36
Product description:Ezetimibe intermediates for the treatment of cardiovascular diseases. Ezetimibe is a novel cholesterol absorption inhibitor with excellent pharmacological activity and safety, is in the field of pharmacological effects in regulating lipid relatively new category, has a broad market prospect. Nevertheless, long-term effects of ezetimibe ezetimibe on cardiovascular disease morbidity and mortality in the future remains to be further examined clinically.
